Probiotics: current landscape and future horizons
- PMID: 31114711
- PMCID: PMC6511921
- DOI: 10.4155/fsoa-2019-0004
Probiotics: current landscape and future horizons
Abstract
In recent years there has been a rapid rise in interest for the application of probiotic supplements to act as mediators in health and disease. This appeal is predominantly due to ever-increasing evidence of the interaction of the microbiota and pathophysiological processes of disease within the human host. This narrative review considers the current landscape of the probiotic industry and its research, and discusses current pitfalls in the lack of translation from laboratory science to clinical application. Future considerations into how industry and academia must adapt probiotic research to maximize success are suggested, including more targeted application of probiotic strains dependent on individual capabilities as well as application of multiple advanced analytical technologies to further understand and accelerate microbiome science.
Keywords: disease; health; metabolomics; metagenomics; metatranscriptomics; microbiome; probiotics; proteomics.
Conflict of interest statement
Financial & competing interests disclosure RLJ Day and AJ Harper are employees of ADM Protexin Ltd. and RM Woods is funded through a Yakult Honsha Co., Ltd research grant. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. No writing assistance was utilized in the production of this manuscript.
Figures
Similar articles
-
Tackling probiotic and gut microbiota functionality through proteomics.J Proteomics. 2016 Sep 16;147:28-39. doi: 10.1016/j.jprot.2016.03.023. Epub 2016 Mar 18. J Proteomics. 2016. PMID: 27003613 Review.
-
Pro-biomics: Omics Technologies To Unravel the Role of Probiotics in Health and Disease.Adv Nutr. 2021 Oct 1;12(5):1802-1820. doi: 10.1093/advances/nmab014. Adv Nutr. 2021. PMID: 33626128 Free PMC article. Review.
-
The Application of Metabolomics to Probiotic and Prebiotic Interventions in Human Clinical Studies.Metabolites. 2020 Mar 24;10(3):120. doi: 10.3390/metabo10030120. Metabolites. 2020. PMID: 32213886 Free PMC article. Review.
-
Microbiome 101: Studying, Analyzing, and Interpreting Gut Microbiome Data for Clinicians.Clin Gastroenterol Hepatol. 2019 Jan;17(2):218-230. doi: 10.1016/j.cgh.2018.09.017. Epub 2018 Sep 18. Clin Gastroenterol Hepatol. 2019. PMID: 30240894 Free PMC article. Review.
-
The gut microbiome as a target for prevention and treatment of hyperglycaemia in type 2 diabetes: from current human evidence to future possibilities.Diabetologia. 2017 Jun;60(6):943-951. doi: 10.1007/s00125-017-4278-3. Epub 2017 Apr 22. Diabetologia. 2017. PMID: 28434033 Free PMC article. Review.
Cited by
-
Probiotic potential of Saccharomyces cerevisiae GILA with alleviating intestinal inflammation in a dextran sulfate sodium induced colitis mouse model.Sci Rep. 2023 Apr 24;13(1):6687. doi: 10.1038/s41598-023-33958-7. Sci Rep. 2023. PMID: 37095161 Free PMC article.
-
Prospective Use of Probiotics to Maintain Astronaut Health during Spaceflight.Life (Basel). 2023 Mar 8;13(3):727. doi: 10.3390/life13030727. Life (Basel). 2023. PMID: 36983881 Free PMC article. Review.
-
Potential application of the probiotic Bacillus licheniformis as an adjuvant in the treatment of diseases in humans and animals: A systematic review.Front Microbiol. 2022 Sep 26;13:993451. doi: 10.3389/fmicb.2022.993451. eCollection 2022. Front Microbiol. 2022. PMID: 36225361 Free PMC article. Review.
-
ProbResist: a database for drug-resistant probiotic bacteria.Database (Oxford). 2022 Aug 13;2022:baac064. doi: 10.1093/database/baac064. Database (Oxford). 2022. PMID: 35962763 Free PMC article.
-
In vitro evaluation of antiviral activity of Shouchella clausii probiotic strain and bacterial supernatant against herpes simplex virus type 1.Arch Microbiol. 2022 Jul 25;204(8):522. doi: 10.1007/s00203-022-03137-9. Arch Microbiol. 2022. PMID: 35879582
References
-
- Thaiss CA, Zmora N, Levy M, Elinav E. The microbiome and innate immunity. Nature 535(7610), 65–74 (2016). - PubMed
-
- Fetissov SO. Role of the gut microbiota in host appetite control: bacterial growth to animal feeding behaviour. Nat. Rev. Endocrinol. 13(1), 11–25 (2017). - PubMed
-
- van de Wouw M, Schellekens H, Dinan TG, Cryan JF. Microbiota-gut-brain axis: modulator of host metabolism and appetite. J. Nutr. 147(5), 727–745 (2017). - PubMed
Publication types
LinkOut - more resources
Full Text Sources